Mingxi Jing

Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67

Junnan Xu, Xiangyu Guo, Mingxi Jing et al. · OncoTargets and Therapy · 2018 · 36 citations · Full text

Life Sciences, Bioinformatics, Cancer Biology +17

Identifying distinctive tissue and fecal microbial signatures and the tumor-promoting effects of deoxycholic acid on breast cancer

Na Wang, Jun Yang, Wenjie Han et al. · Frontiers in Cellular and Infection Microbiology · 2022 · 32 citations · Full text

Life Sciences, Cancer Biology, Microbiology +17

Does a ketogenic diet as an adjuvant therapy for drug treatment enhance chemotherapy sensitivity and reduce target lesions in patients with locally recurrent or metastatic Her-2-negative breast cancer? Study protocol for a randomized controlled trial

Yan Wang, Mingxi Jing, Lei Jiang et al. · Trials · 2020 · 19 citations · Full text

Medicine, Oncology, Pharmacology +14

Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer

Junnan Xu, Tao Sun, Xiangyu Guo et al. · Oncology Letters · 2017 · 13 citations · Full text

Medicine, Genetics, Oncology +17